Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CarobWay is an Israeli biotechnology and food-tech company that specializes in the cultivation and processing of carob to produce high-value bioactive ingredients. The company has developed a vertically integrated model that spans from sustainable agriculture to advanced extraction technologies, focusing on the recovery of D-chiro-inositol (DCI) and other functional compounds. These ingredients are primarily targeted at the nutraceutical and pharmaceutical industries for the management of metabolic health conditions, including Type 2 diabetes and Polycystic Ovary Syndrome (PCOS). CarobWay leverages a proprietary database of carob varieties to optimize the yield of specific health-promoting molecules. Their mission is to provide natural, plant-based alternatives for blood glucose regulation and hormonal balance while promoting environmental sustainability.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CarobWay.